Akèy › Limfangyoleyomiomatoz
Etid klinik pou Limfangyoleyomiomatoz ap rekrite nan Etazini
6 etid pou Limfangyoleyomiomatoz ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Study of the Disease Process of Lymphangioleiomyomatosis
Ap rekriteEtid obsèvasyon
Laj 16 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT00001465Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Ap rekriteFaz 1/2
Laj 18 a 100 · Fanm · Mizajou Aug 31, 2026 · NCT01799538TSC Biosample Repository and Natural History Database
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 24, 2026 · NCT05676099Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jan 23, 2026 · NCT06160310Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
Ap rekriteFaz 1
Laj 18 a 64 · Fanm · Mizajou Jan 21, 2026 · NCT06889168Safety and Durability of Sirolimus for Treatment of LAM
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Dec 24, 2024 · NCT02432560Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.